How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis.
Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to be efficacious to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). However, the target patients, the type of NSAID, the route of administration and the time of drug delivery remain unclear, as well as...
Main Authors: | Ignasi Puig, Xavier Calvet, Mireia Baylina, Álvaro Isava, Pau Sort, Jordina Llaó, Francesc Porta, Francesc Vida |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3968039?pdf=render |
Similar Items
-
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
by: R. L. J. van Wanrooij, et al.
Published: (2019-07-01) -
Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
by: Lei-Min Yu, et al.
Published: (2018-01-01) -
Should we incorporate topical epinephrine in the ESGE guideline on prevention of post-ERCP pancreatitis?
by: E. Toussaint, et al.
Published: (2020-07-01) -
Prevention of Post-ERCP Pancreatitis
by: F. Donnellan, et al.
Published: (2012-01-01) -
Are Patients Informed When They Consent to ERCP?
by: Sinead O’Sullivan, et al.
Published: (2002-01-01)